Compare First Trust NASDAQ Cybersecurity ETF (CIBR) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ Cybersecurity ETF vs Inovio Pharmaceuticals Inc — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $100.01, while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CIBR | INO | |
|---|---|---|
52-Week High | $100.60 | $2.87 |
52-Week Low | $60.74 | $0.66 |
Market Cap | — | $78.55M |
Sector | — | Health |
Enterprise Value | — | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
